EGFR and renal carcinoma: For example, the GPCR known as PAR‐1 could transactivate the epidermal growth factor receptor (EGFR) to promote migration of human colon carcinoma cells 10, gastric cancer cell 11, renal carcinoma cells 12, and human keratinocytes 13.